Sujata Vaidyanathan

Pharmacologic Demonstration of the Synergistic Effects of a Combination of the Renin Inhibitor Aliskiren and the AT1 Receptor Antagonist Valsartan on the Angiotensin II–Renin Feedback Interruption

Michel Azizi, Joël Ménard, Alvine Bissery et al. · Journal of the American Society of Nephrology · 2004 · 234 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers

Felix Waldmeier, Ulrike Glaenzel, B. Wirz et al. · Drug Metabolism and Disposition · 2007 · 127 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.

R. Blake Pepinsky, Doreen LePage, Alan Gill et al. · PubMed · 2001 · 119 citations

Medicine, Pharmacokinetics, Pharmacology +14

A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial

Marcos Pedrosa, Star Seyedkazemi, Sven Francque et al. · Contemporary Clinical Trials · 2019 · 112 citations

Medicine, Pharmacology, Pharmacotherapy +10

Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P‐Glycoprotein in the Disposition of Aliskiren

Sujata Vaidyanathan, Gian Camenisch, Helmut Schuetz et al. · The Journal of Clinical Pharmacology · 2008 · 103 citations

Medicine, Pharmacokinetics, Pharmacology +13